DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Ravaud A, Motzer RJ, Pandha HS. et al.
Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy.
N Engl J Med 2016;
375: 2246-2254
DOI: 10.1056/NEJMoa1611406.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.